FR2279414B1 - - Google Patents

Info

Publication number
FR2279414B1
FR2279414B1 FR7426121A FR7426121A FR2279414B1 FR 2279414 B1 FR2279414 B1 FR 2279414B1 FR 7426121 A FR7426121 A FR 7426121A FR 7426121 A FR7426121 A FR 7426121A FR 2279414 B1 FR2279414 B1 FR 2279414B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7426121A
Other languages
French (fr)
Other versions
FR2279414A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB121473A priority Critical patent/GB1422193A/en
Priority to AU70802/74A priority patent/AU487061B2/en
Priority to BE146571A priority patent/BE817670A/xx
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Priority to FR7426121A priority patent/FR2279414A1/fr
Publication of FR2279414A1 publication Critical patent/FR2279414A1/fr
Application granted granted Critical
Publication of FR2279414B1 publication Critical patent/FR2279414B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7426121A 1974-07-26 1974-07-26 Composition pharmaceutique comprenant des composes de magnesium et de potassium Granted FR2279414A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB121473A GB1422193A (en) 1974-07-26 1974-04-09 Pharmaceutical compositions
AU70802/74A AU487061B2 (en) 1974-07-26 1974-07-03 Pharmaceutical compositions
BE146571A BE817670A (fr) 1974-07-26 1974-07-15 Compositions pharmaceutiques comprenant des composes de magnesium et de potassium.
FR7426121A FR2279414A1 (fr) 1974-07-26 1974-07-26 Composition pharmaceutique comprenant des composes de magnesium et de potassium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7426121A FR2279414A1 (fr) 1974-07-26 1974-07-26 Composition pharmaceutique comprenant des composes de magnesium et de potassium

Publications (2)

Publication Number Publication Date
FR2279414A1 FR2279414A1 (fr) 1976-02-20
FR2279414B1 true FR2279414B1 (cg-RX-API-DMAC10.html) 1978-07-21

Family

ID=9141793

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7426121A Granted FR2279414A1 (fr) 1974-07-26 1974-07-26 Composition pharmaceutique comprenant des composes de magnesium et de potassium

Country Status (4)

Country Link
AU (1) AU487061B2 (cg-RX-API-DMAC10.html)
BE (1) BE817670A (cg-RX-API-DMAC10.html)
FR (1) FR2279414A1 (cg-RX-API-DMAC10.html)
GB (1) GB1422193A (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI60107C (fi) * 1978-02-24 1982-12-13 Suomen Laeaeketehdas Oy Salco Som krydda eller som konserveringsmedel foer livsmedel anvaendbar bordssaltprodukt
US4259315A (en) 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
GB8308126D0 (en) * 1983-03-24 1983-05-05 Bloch M Pharmaceutical compositions
DE3402878A1 (de) * 1984-01-27 1985-08-01 Algina AG, Zug Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen als arzneimittel
US4954349A (en) * 1987-09-11 1990-09-04 Ciba-Geigy Corporation Oral magnesium and potassium compositions and use
CH677612A5 (cg-RX-API-DMAC10.html) * 1987-09-11 1991-06-14 Ciba Geigy Ag
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
EP1661575A1 (en) * 2004-11-26 2006-05-31 ZAMBON GROUP S.p.A. Use of magnesium in the treatment of disorders related to hormonal variations in women
US8163301B2 (en) 2007-03-22 2012-04-24 Magceutics, Inc. Magnesium compositions and uses thereof for metabolic disorders
EP2448413A4 (en) * 2009-07-01 2013-02-13 Magceutics Inc SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF

Also Published As

Publication number Publication date
FR2279414A1 (fr) 1976-02-20
AU7080274A (en) 1976-01-08
BE817670A (fr) 1975-01-15
AU487061B2 (en) 1976-01-08
GB1422193A (en) 1976-01-21

Similar Documents

Publication Publication Date Title
FR2279414B1 (cg-RX-API-DMAC10.html)
AU495028B2 (cg-RX-API-DMAC10.html)
FI50507B (cg-RX-API-DMAC10.html)
AR199810A1 (cg-RX-API-DMAC10.html)
CS173863B1 (cg-RX-API-DMAC10.html)
CS167110B1 (cg-RX-API-DMAC10.html)
AU7478474A (cg-RX-API-DMAC10.html)
AU7470174A (cg-RX-API-DMAC10.html)
AU7237274A (cg-RX-API-DMAC10.html)
BG20180A1 (cg-RX-API-DMAC10.html)
BG20017A1 (cg-RX-API-DMAC10.html)
AU479634A (cg-RX-API-DMAC10.html)
AU480759A (cg-RX-API-DMAC10.html)
DD118156A1 (cg-RX-API-DMAC10.html)
AU480783A (cg-RX-API-DMAC10.html)
DD111455A1 (cg-RX-API-DMAC10.html)
CH594911A5 (cg-RX-API-DMAC10.html)
AU480879A (cg-RX-API-DMAC10.html)
CH591137A5 (cg-RX-API-DMAC10.html)
CH586787A5 (cg-RX-API-DMAC10.html)
AU480902A (cg-RX-API-DMAC10.html)
CH584019A5 (cg-RX-API-DMAC10.html)
AU480922A (cg-RX-API-DMAC10.html)
BG19872A1 (cg-RX-API-DMAC10.html)
AU479969A (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse